Intramuscular Olanzapine in the Management of Behavioral and Psychological Symptoms in Hospitalized Older Adults: A Retrospective Descriptive Study

Table 1

Baseline demographic characteristics of older patients prescribed olanzapine.

	Received olanzapine	No olanzapine	All cases
	Age, mean (years)	79.6	79.0	79.3
Female	19 (55.9%)	26 (51%)	45 (52.9%)
Admission from
Home	18 (52.9%)	41 (80.4%)	59 (69.4%)
Another hospital	4 (11.8%)	2 (3.9%)	6 (7.1%)
Retirement/LTC facilities	12 (35.3%)	8 (15.7%)	20 (23.5%)
Discharge destination
Home	10 (29.4%)	20 (39.2%)	30 (35.3%)
Another institution	6 (17.6%)	6 (11.8%)	12 (14.1%)
Retirement/LTC facilities	18 (53.0%)	23 (45.1%)	41 (48.2%)
Death	0	2 (3.9%)	2 (2.4%)
Types of patients
Psychiatry	22 (64.7%)	29 (56.9%)	51 (60.0%)
General medicine	12 (35.3%)	21 (41.2%)	31 (36.4%)
Surgery	0	2 (3.9%)	2 (2.4%)
Intensive care unit	0	1 (2.0%)	1 (1.2%)
Comorbidities
Cognitive impairment/dementia	21 (61.8%)	33 (64.7%)	54 (63.5%)
Delirium	9 (26.5%)	16 (31.4%)	25 (29.4%)
Psychiatric disorders	19 (55.9%)	24 (47.1%)	43 (50.6%)
Neurological disorder	5 (14.7%)	6 (11.8%)	11 (12.9%)
Insomnia	3 (8.8%)	5 (9.8%)	8 (9.4%)
Pain	0	1 (1.9%)	1 (1.2%)
Acute infection	7 (20.6%)	13 (25.5%)	20 (23.5%)
Other	6 (17.6%)	5 (9.8%)	11 (12.9%)
Number of comorbidities
1	17 (50.0%)	25 (49.0%)	42 (49.4%)
2	11 (32.3%)	10 (19.6%)	21 (24.7%)
3	2 (5.9%)	10 (19.6%)	12 (14.1%)
4	4 (11.8%)	6 (11.8%)	10 (11.8%)
Concurrent psychotropic medications
Other antipsychotics	29 (85.3%)	41 (80.4%)	70 (83.4%)
Benzodiazepines	11 (32.4%)	10 (19.6%)	21 (24.7%)
Antidepressants	18 (52.9%)	18 (35.3%)	36 (42.4%)
Antidementia medications	7 (20.6%)	14 (27.4%)	21 (24.7%)
Mood stabilizer	4 (11.8%)	4 (7.8%)	8 (9.4%)
Pain medications	0	1 (1.96%)	1 (1.2%)
Other sedatives	0	2 (3.9%)	2 (2.4%)
Number of psychotropic medications (nonantipsychotics)
0	8 (23.5%)	13 (25.5%)	21 (24.7%)
1	9 (26.5%)	20 (39.2%)	29 (34.1%)
2	14 (41.2%)	17 (33.3%)	31 (36.4%)
3	1 (2.9%)	1 (2.0%)	2 (2.4%)
4	2 (5.9%)	0	2 (2.4%)

LTC: long-term care.